25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

UMediC Group Berhad
Buy, Hold or Sell?

Let's analyze Umedic together

I guess you are interested in UMediC Group Berhad. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of UMediC Group Berhad. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about UMediC Group Berhad

I send you an email if I find something interesting about UMediC Group Berhad.

1. Quick Overview

1.1. Quick analysis of Umedic (30 sec.)










1.2. What can you expect buying and holding a share of Umedic? (30 sec.)

How much money do you get?

How much money do you get?
RM0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
RM0.20
Expected worth in 1 year
RM0.22
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
RM0.02
Return On Investment
4.2%

For what price can you sell your share?

Current Price per Share
RM0.58
Expected price per share
RM0.565 - RM0.66
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Umedic (5 min.)




Live pricePrice per Share (EOD)
RM0.58

2.2. Growth of Umedic (5 min.)




Is Umedic growing?

Current yearPrevious yearGrowGrow %
How rich?$16.7m$13.8m$2.1m13.5%

How much money is Umedic making?

Current yearPrevious yearGrowGrow %
Making money$500.7k$571.1k-$70.3k-14.0%
Net Profit Margin16.6%21.4%--

How much money comes from the company's main activities?

2.3. Financial Health of Umedic (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Umedic?

Welcome investor! Umedic's management wants to use your money to grow the business. In return you get a share of Umedic.

First you should know what it really means to hold a share of Umedic. And how you can make/lose money.

Speculation

The Price per Share of Umedic is RM0.58. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Umedic.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Umedic, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is RM0.20. Based on the TTM, the Book Value Change Per Share is RM0.01 per quarter. Based on the YOY, the Book Value Change Per Share is RM0.04 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is RM0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Umedic.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 RM% of Price per ShareRM% of Price per ShareRM% of Price per ShareRM% of Price per ShareRM% of Price per Share
Usd Eps0.000.2%0.000.2%0.000.3%0.000.2%0.000.2%
Usd Book Value Change Per Share0.000.2%0.000.2%0.011.7%0.011.0%0.011.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.2%0.000.2%0.011.7%0.011.0%0.011.0%
Usd Price Per Share0.13-0.14-0.17-0.16-0.16-
Price to Earnings Ratio29.13-28.44-29.38-28.91-28.91-
Price-to-Total Gains Ratio116.87-112.69-83.85-98.27-98.27-
Price to Book Ratio2.88-3.34-4.58-3.96-3.96-
Price-to-Total Gains Ratio116.87-112.69-83.85-98.27-98.27-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.129862
Number of shares7700
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.01
Usd Total Gains Per Share0.000.01
Gains per Quarter (7700 shares)10.4243.00
Gains per Year (7700 shares)41.69172.01
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1042320172162
2083740344334
301251160516506
401671580688678
502082000860850
60250242010321022
70292284012041194
80333326013761366
90375368015481538
100417410017201710

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%8.00.00.0100.0%8.00.00.0100.0%8.00.00.0100.0%8.00.00.0100.0%
Book Value Change Per Share4.00.00.0100.0%8.00.00.0100.0%8.00.00.0100.0%8.00.00.0100.0%8.00.00.0100.0%
Dividend per Share0.00.04.00.0%0.00.08.00.0%0.00.08.00.0%0.00.08.00.0%0.00.08.00.0%
Total Gains per Share4.00.00.0100.0%8.00.00.0100.0%8.00.00.0100.0%8.00.00.0100.0%8.00.00.0100.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of UMediC Group Berhad compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0050.006-19%0.044-89%0.025-80%0.025-80%
Book Value Per Share--0.2000.191+5%0.165+21%0.178+12%0.178+12%
Current Ratio--10.3249.467+9%7.978+29%8.723+18%8.723+18%
Debt To Asset Ratio--0.1040.118-11%0.179-42%0.148-30%0.148-30%
Debt To Equity Ratio--0.1180.135-13%0.222-47%0.178-34%0.178-34%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--206318259.200227931202.910-9%267941679.790-23%247936441.350-17%247936441.350-17%
Eps--0.0050.006-18%0.007-28%0.006-23%0.006-23%
Ev To Ebitda Ratio--infinfnan%infnan%infnan%infnan%
Ev To Sales Ratio--3.9514.338-9%5.667-30%5.002-21%5.002-21%
Free Cash Flow Per Share--0.0020.000+117%-0.002+232%-0.001+175%-0.001+175%
Free Cash Flow To Equity Per Share--0.0020.000+117%-0.002+232%-0.001+175%-0.001+175%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Market Cap216867809.280+1%214998259.200237432860.160-9%281367287.040-24%259400073.600-17%259400073.600-17%
Net Profit Margin--0.1410.166-15%0.214-34%0.190-26%0.190-26%
Operating Margin----0%-0%-0%-0%
Operating Ratio--1.4681.361+8%1.346+9%1.354+8%1.354+8%
Pb Ratio2.907+1%2.8823.339-14%4.581-37%3.960-27%3.960-27%
Pe Ratio29.386+1%29.13328.437+2%29.384-1%28.911+1%28.911+1%
Price Per Share0.580+1%0.5750.635-9%0.753-24%0.694-17%0.694-17%
Price To Free Cash Flow Ratio77.342+1%76.6767.450+929%-49.333+164%-20.941+127%-20.941+127%
Price To Total Gains Ratio117.885+1%116.869112.692+4%83.849+39%98.270+19%98.270+19%
Quick Ratio--5.0075.285-5%4.697+7%4.991+0%4.991+0%
Return On Assets--0.0220.028-20%0.034-35%0.031-28%0.031-28%
Return On Equity--0.0250.032-21%0.042-40%0.037-32%0.037-32%
Total Gains Per Share--0.0050.006-19%0.044-89%0.025-80%0.025-80%
Usd Book Value--16705850.70015967560.153+5%13809441.789+21%14888500.971+12%14888500.971+12%
Usd Book Value Change Per Share--0.0010.001-19%0.010-89%0.006-80%0.006-80%
Usd Book Value Per Share--0.0450.043+5%0.037+21%0.040+12%0.040+12%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--46194658.23551033796.332-9%59992142.105-23%55512969.218-17%55512969.218-17%
Usd Eps--0.0010.001-18%0.002-28%0.001-23%0.001-23%
Usd Free Cash Flow--156953.900-27199.316+117%-207107.108+232%-117153.212+175%-117153.212+175%
Usd Free Cash Flow Per Share--0.0000.000+117%-0.001+232%0.000+175%0.000+175%
Usd Free Cash Flow To Equity Per Share--0.0000.000+117%-0.001+232%0.000+175%0.000+175%
Usd Market Cap48556702.498+1%48138110.23553161217.390-9%62998135.568-24%58079676.479-17%58079676.479-17%
Usd Price Per Share0.130+1%0.1290.142-9%0.168-24%0.155-17%0.155-17%
Usd Profit--413095.500500791.141-18%571131.621-28%535961.381-23%535961.381-23%
Usd Revenue--2923014.5002972328.587-2%2722760.411+7%2847544.499+3%2847544.499+3%
Usd Total Gains Per Share--0.0010.001-19%0.010-89%0.006-80%0.006-80%
 EOD+4 -4MRQTTM+14 -21YOY+17 -185Y+16 -1910Y+16 -19

3.3 Fundamental Score

Let's check the fundamental score of UMediC Group Berhad based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1529.386
Price to Book Ratio (EOD)Between0-12.907
Net Profit Margin (MRQ)Greater than00.141
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than15.007
Current Ratio (MRQ)Greater than110.324
Debt to Asset Ratio (MRQ)Less than10.104
Debt to Equity Ratio (MRQ)Less than10.118
Return on Equity (MRQ)Greater than0.150.025
Return on Assets (MRQ)Greater than0.050.022
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of UMediC Group Berhad based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.149
Ma 20Greater thanMa 500.591
Ma 50Greater thanMa 1000.608
Ma 100Greater thanMa 2000.603
OpenGreater thanClose0.570
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About UMediC Group Berhad

UMediC Group Berhad, an investment holding company, develops, manufactures, markets, and distributes medical devices and consumables in Malaysia, the Asia Pacific, the Americas, Europe, the Middle East, Africa, and Oceania. The company operates nursing homes and healthcare centers, and other related services; markets and distributes laboratory equipment and consumables; and provides after-sales services. It offers HYDROX prefilled humidifiers and nebulizers; AIRDROX inhaler spacers; FLEXIDROX water for inhalation bag; and products such as hospital furniture, life-support solution, MR compatible monitoring solution, oxygen therapy and suction solution, patient monitoring system, resuscitation care, ultrasound solution, women and childcare, critical care solution, and anaesthesia solution. In addition, the company provides services, including clinical training on equipment, planned preventive maintenance, installations, equipment pre-checks, equipment servicing and repair, 24/7 emergency call-out, unlimited break down call, and spare parts procurement. The company was formerly known as UMediC Group Sdn Bhd and changed its name to UMediC Group Berhad in September 2021. UMediC Group Berhad was incorporated in 2021 and is headquartered in Penang, Malaysia. UMediC Group Berhad is a subsidiary of UMediC Capital Sdn Bhd.

Fundamental data was last updated by Penke on 2025-02-08 00:15:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Umedic earns for each RM1 of revenue.

  • Above 10% is considered healthy but always compare Umedic to the Medical Devices industry mean.
  • A Net Profit Margin of 14.1% means that RM0.14 for each RM1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of UMediC Group Berhad:

  • The MRQ is 14.1%. The company is making a huge profit. +2
  • The TTM is 16.6%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ14.1%TTM16.6%-2.5%
TTM16.6%YOY21.4%-4.8%
TTM16.6%5Y19.0%-2.4%
5Y19.0%10Y19.0%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ14.1%-6.6%+20.7%
TTM16.6%-14.2%+30.8%
YOY21.4%-14.5%+35.9%
5Y19.0%-14.8%+33.8%
10Y19.0%-14.5%+33.5%
4.3.1.2. Return on Assets

Shows how efficient Umedic is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Umedic to the Medical Devices industry mean.
  • 2.2% Return on Assets means that Umedic generated RM0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of UMediC Group Berhad:

  • The MRQ is 2.2%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.8%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.2%TTM2.8%-0.6%
TTM2.8%YOY3.4%-0.6%
TTM2.8%5Y3.1%-0.3%
5Y3.1%10Y3.1%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.2%-2.3%+4.5%
TTM2.8%-3.0%+5.8%
YOY3.4%-3.9%+7.3%
5Y3.1%-2.8%+5.9%
10Y3.1%-3.6%+6.7%
4.3.1.3. Return on Equity

Shows how efficient Umedic is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Umedic to the Medical Devices industry mean.
  • 2.5% Return on Equity means Umedic generated RM0.02 for each RM1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of UMediC Group Berhad:

  • The MRQ is 2.5%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 3.2%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.5%TTM3.2%-0.7%
TTM3.2%YOY4.2%-1.0%
TTM3.2%5Y3.7%-0.5%
5Y3.7%10Y3.7%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.5%-2.9%+5.4%
TTM3.2%-3.9%+7.1%
YOY4.2%-4.1%+8.3%
5Y3.7%-4.1%+7.8%
10Y3.7%-5.0%+8.7%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of UMediC Group Berhad.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Umedic is operating .

  • Measures how much profit Umedic makes for each RM1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Umedic to the Medical Devices industry mean.
  • An Operating Margin of 0.0% means the company generated RM0.00  for each RM1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of UMediC Group Berhad:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--13.2%+13.2%
TTM--21.6%+21.6%
YOY--12.0%+12.0%
5Y--16.3%+16.3%
10Y--15.2%+15.2%
4.3.2.2. Operating Ratio

Measures how efficient Umedic is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.47 means that the operating costs are RM1.47 for each RM1 in net sales.

Let's take a look of the Operating Ratio trends of UMediC Group Berhad:

  • The MRQ is 1.468. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.361. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.468TTM1.361+0.107
TTM1.361YOY1.346+0.015
TTM1.3615Y1.354+0.008
5Y1.35410Y1.3540.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4681.288+0.180
TTM1.3611.297+0.064
YOY1.3461.324+0.022
5Y1.3541.360-0.006
10Y1.3541.304+0.050
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of UMediC Group Berhad.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Umedic is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 10.32 means the company has RM10.32 in assets for each RM1 in short-term debts.

Let's take a look of the Current Ratio trends of UMediC Group Berhad:

  • The MRQ is 10.324. The company is very able to pay all its short-term debts. +2
  • The TTM is 9.467. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ10.324TTM9.467+0.857
TTM9.467YOY7.978+1.489
TTM9.4675Y8.723+0.745
5Y8.72310Y8.7230.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ10.3242.595+7.729
TTM9.4672.712+6.755
YOY7.9782.910+5.068
5Y8.7233.515+5.208
10Y8.7233.470+5.253
4.4.3.2. Quick Ratio

Measures if Umedic is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Umedic to the Medical Devices industry mean.
  • A Quick Ratio of 5.01 means the company can pay off RM5.01 for each RM1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of UMediC Group Berhad:

  • The MRQ is 5.007. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 5.285. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ5.007TTM5.285-0.278
TTM5.285YOY4.697+0.588
TTM5.2855Y4.991+0.294
5Y4.99110Y4.9910.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ5.0071.488+3.519
TTM5.2851.586+3.699
YOY4.6971.875+2.822
5Y4.9912.415+2.576
10Y4.9912.550+2.441
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of UMediC Group Berhad.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Umedic assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Umedic to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.10 means that Umedic assets are financed with 10.4% credit (debt) and the remaining percentage (100% - 10.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of UMediC Group Berhad:

  • The MRQ is 0.104. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.118. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.104TTM0.118-0.014
TTM0.118YOY0.179-0.061
TTM0.1185Y0.148-0.030
5Y0.14810Y0.1480.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1040.403-0.299
TTM0.1180.406-0.288
YOY0.1790.369-0.190
5Y0.1480.429-0.281
10Y0.1480.451-0.303
4.5.4.2. Debt to Equity Ratio

Measures if Umedic is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Umedic to the Medical Devices industry mean.
  • A Debt to Equity ratio of 11.8% means that company has RM0.12 debt for each RM1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of UMediC Group Berhad:

  • The MRQ is 0.118. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.135. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.118TTM0.135-0.017
TTM0.135YOY0.222-0.087
TTM0.1355Y0.178-0.043
5Y0.17810Y0.1780.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1180.580-0.462
TTM0.1350.623-0.488
YOY0.2220.548-0.326
5Y0.1780.644-0.466
10Y0.1780.717-0.539
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every RM1 in earnings Umedic generates.

  • Above 15 is considered overpriced but always compare Umedic to the Medical Devices industry mean.
  • A PE ratio of 29.13 means the investor is paying RM29.13 for every RM1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of UMediC Group Berhad:

  • The EOD is 29.386. Based on the earnings, the company is overpriced. -1
  • The MRQ is 29.133. Based on the earnings, the company is overpriced. -1
  • The TTM is 28.437. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD29.386MRQ29.133+0.253
MRQ29.133TTM28.437+0.695
TTM28.437YOY29.384-0.947
TTM28.4375Y28.911-0.473
5Y28.91110Y28.9110.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD29.386-1.499+30.885
MRQ29.133-1.755+30.888
TTM28.437-2.155+30.592
YOY29.384-3.166+32.550
5Y28.911-2.530+31.441
10Y28.911-2.137+31.048
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of UMediC Group Berhad:

  • The EOD is 77.342. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The MRQ is 76.676. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The TTM is 7.450. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD77.342MRQ76.676+0.667
MRQ76.676TTM7.450+69.226
TTM7.450YOY-49.333+56.783
TTM7.4505Y-20.941+28.391
5Y-20.94110Y-20.9410.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD77.342-1.789+79.131
MRQ76.676-1.987+78.663
TTM7.450-2.233+9.683
YOY-49.333-5.419-43.914
5Y-20.941-3.825-17.116
10Y-20.941-4.906-16.035
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Umedic is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 2.88 means the investor is paying RM2.88 for each RM1 in book value.

Let's take a look of the Price to Book Ratio trends of UMediC Group Berhad:

  • The EOD is 2.907. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.882. Based on the equity, the company is underpriced. +1
  • The TTM is 3.339. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.907MRQ2.882+0.025
MRQ2.882TTM3.339-0.457
TTM3.339YOY4.581-1.242
TTM3.3395Y3.960-0.621
5Y3.96010Y3.9600.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD2.9072.085+0.822
MRQ2.8822.234+0.648
TTM3.3392.408+0.931
YOY4.5813.024+1.557
5Y3.9604.282-0.322
10Y3.9604.589-0.629
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-10-31. Currency in MYR. All numbers in thousands.

Summary
Total Assets83,293
Total Liabilities8,680
Total Stockholder Equity73,830
 As reported
Total Liabilities 8,680
Total Stockholder Equity+ 73,830
Total Assets = 83,293

Assets

Total Assets83,293
Total Current Assets49,702
Long-term Assets33,591
Total Current Assets
Cash And Cash Equivalents 9,383
Short-term Investments 4,983
Net Receivables 19,122
Inventory 14,922
Total Current Assets  (as reported)49,702
Total Current Assets  (calculated)48,410
+/- 1,292
Long-term Assets
Property Plant Equipment 33,304
Goodwill 287
Long-term Assets  (as reported)33,591
Long-term Assets  (calculated)33,591
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities4,814
Long-term Liabilities3,866
Total Stockholder Equity73,830
Total Current Liabilities
Short Long Term Debt 477
Accounts payable 3,933
Total Current Liabilities  (as reported)4,814
Total Current Liabilities  (calculated)4,410
+/- 404
Long-term Liabilities
Long term Debt 203
Capital Lease Obligations Min Short Term Debt5
Long-term Liabilities  (as reported)3,866
Long-term Liabilities  (calculated)208
+/- 3,658
Total Stockholder Equity
Retained Earnings 36,333
Total Stockholder Equity (as reported)73,830
Total Stockholder Equity (calculated)36,333
+/- 37,497
Other
Capital Stock44,348
Common Stock Shares Outstanding 373,910
Net Invested Capital 74,510
Net Working Capital 44,888
Property Plant and Equipment Gross 33,304



6.2. Balance Sheets Structured

Currency in MYR. All numbers in thousands.

 Trend2024-10-312024-07-312024-04-302024-01-312023-10-312023-07-312023-04-302023-01-312022-10-31
> Total Assets 
0
75,488
74,882
73,292
76,748
77,570
79,698
82,708
83,293
83,29382,70879,69877,57076,74873,29274,88275,4880
   > Total Current Assets 
0
48,232
46,947
43,824
46,678
48,056
50,306
49,429
49,702
49,70249,42950,30648,05646,67843,82446,94748,2320
       Cash And Cash Equivalents 
0
3,140
3,070
6,107
6,718
5,928
3,436
4,232
9,383
9,3834,2323,4365,9286,7186,1073,0703,1400
       Short-term Investments 
0
20,219
18,360
11,874
10,471
11,402
12,050
9,278
4,983
4,9839,27812,05011,40210,47111,87418,36020,2190
       Net Receivables 
0
10,841
10,407
11,947
17,494
16,895
19,239
17,423
19,122
19,12217,42319,23916,89517,49411,94710,40710,8410
   > Long-term Assets 
0
27,256
27,935
29,468
30,070
29,514
29,392
33,279
33,591
33,59133,27929,39229,51430,07029,46827,93527,2560
       Property Plant Equipment 
0
26,854
27,398
29,181
29,783
29,227
29,105
32,992
33,304
33,30432,99229,10529,22729,78329,18127,39826,8540
       Goodwill 
0
0
287
287
287
287
287
287
287
28728728728728728728700
> Total Liabilities 
0
17,899
14,812
9,815
11,176
9,430
9,962
9,935
8,680
8,6809,9359,9629,43011,1769,81514,81217,8990
   > Total Current Liabilities 
0
9,066
7,995
3,751
5,165
4,874
5,306
6,025
4,814
4,8146,0255,3064,8745,1653,7517,9959,0660
       Short Long Term Debt 
0
577
380
711
584
448
320
606
477
4776063204485847113805770
       Accounts payable 
0
7,984
7,448
1,301
3,811
3,638
4,081
2,585
3,933
3,9332,5854,0813,6383,8111,3017,4487,9840
   > Long-term Liabilities 
0
8,833
6,817
6,064
6,011
4,556
4,656
3,910
3,866
3,8663,9104,6564,5566,0116,0646,8178,8330
> Total Stockholder Equity
0
57,589
59,624
62,994
64,884
67,364
68,947
71,985
73,830
73,83071,98568,94767,36464,88462,99459,62457,5890
   Common Stock000000000
   Retained Earnings Total Equity000000000
   Accumulated Other Comprehensive Income 000000000
   Capital Surplus 000000000
   Treasury Stock000000000
   Other Stockholders Equity 000000000



6.3. Balance Sheets

Currency in MYR. All numbers in thousands.




6.4. Cash Flows

Currency in MYR. All numbers in thousands.




6.5. Income Statements

Currency in MYR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-07-31. Currency in MYR. All numbers in thousands.

Gross Profit (+$)
totalRevenue54,570
Cost of Revenue-31,899
Gross Profit22,67122,671
 
Operating Income (+$)
Gross Profit22,671
Operating Expense-43,329
Operating Income11,241-20,658
 
Operating Expense (+$)
Research Development0
Selling General Administrative11,430
Selling And Marketing Expenses0
Operating Expense43,32911,430
 
Net Interest Income (+$)
Interest Income0
Interest Expense-99
Other Finance Cost-37
Net Interest Income-136
 
Pretax Income (+$)
Operating Income11,241
Net Interest Income-136
Other Non-Operating Income Expenses0
Income Before Tax (EBT)12,64111,241
EBIT - interestExpense = -99
8,991
9,090
Interest Expense99
Earnings Before Interest and Taxes (EBIT)012,740
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax12,641
Tax Provision-3,344
Net Income From Continuing Ops9,2979,297
Net Income8,991
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0136
 

Technical Analysis of Umedic
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Umedic. The general trend of Umedic is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Umedic's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of UMediC Group Berhad.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.61 < 0.625 < 0.66.

The bearish price targets are: 0.57 > 0.57 > 0.565.

Tweet this
UMediC Group Berhad Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of UMediC Group Berhad. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

UMediC Group Berhad Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of UMediC Group Berhad. The current macd is -0.00712929.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Umedic price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Umedic. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Umedic price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
UMediC Group Berhad Daily Moving Average Convergence/Divergence (MACD) ChartUMediC Group Berhad Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of UMediC Group Berhad. The current adx is 10.52.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Umedic shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
UMediC Group Berhad Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of UMediC Group Berhad. The current sar is 0.5882.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
UMediC Group Berhad Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of UMediC Group Berhad. The current rsi is 38.15. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
UMediC Group Berhad Daily Relative Strength Index (RSI) ChartUMediC Group Berhad Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of UMediC Group Berhad. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Umedic price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
UMediC Group Berhad Daily Stochastic Oscillator ChartUMediC Group Berhad Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of UMediC Group Berhad. The current cci is -136.20071685.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
UMediC Group Berhad Daily Commodity Channel Index (CCI) ChartUMediC Group Berhad Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of UMediC Group Berhad. The current cmo is -29.86055008.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
UMediC Group Berhad Daily Chande Momentum Oscillator (CMO) ChartUMediC Group Berhad Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of UMediC Group Berhad. The current willr is -75.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Umedic is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
UMediC Group Berhad Daily Williams %R ChartUMediC Group Berhad Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of UMediC Group Berhad.

UMediC Group Berhad Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of UMediC Group Berhad. The current atr is 0.01149333.

UMediC Group Berhad Daily Average True Range (ATR) ChartUMediC Group Berhad Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of UMediC Group Berhad. The current obv is -6,772,100.

UMediC Group Berhad Daily On-Balance Volume (OBV) ChartUMediC Group Berhad Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of UMediC Group Berhad. The current mfi is 14.98.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
UMediC Group Berhad Daily Money Flow Index (MFI) ChartUMediC Group Berhad Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for UMediC Group Berhad.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-09-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-23WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-24CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-11-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-11-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-11MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-12STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-13ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-11-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-12-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-12-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-12ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-16RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-12-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-12-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-01-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-01-07STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-01-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-01-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-14MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-01-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-01-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-01-28MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-01-31MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-04STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-06STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-02-12STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside

6.3. Candlestick Patterns

UMediC Group Berhad Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of UMediC Group Berhad based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.149
Ma 20Greater thanMa 500.591
Ma 50Greater thanMa 1000.608
Ma 100Greater thanMa 2000.603
OpenGreater thanClose0.570
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Umedic with someone you think should read this too:
  • Are you bullish or bearish on Umedic? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Umedic? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about UMediC Group Berhad

I send you an email if I find something interesting about UMediC Group Berhad.


Comments

How you think about this?

Leave a comment

Stay informed about UMediC Group Berhad.

Receive notifications about UMediC Group Berhad in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.